AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11246842 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity expended on recreational activities and stair climbing (< 840, 840‐2519, 2520‐6299, > or = 6300 kJ/week)
Number of subjects: 39322
Study 11246842 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity expended on recreational activities and stair climbing among postmenopausal women
Number of subjects: 39322
Study 11246842 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous recreational activity requiring > or = 6 METs
Number of subjects: 39322
Study 11246842 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 39322
Study 10680508 — intervention group
Group type: EXPERIMENTAL
Intervention: Displacement of nasal cartilages
Number of subjects: 38
Study 10680508 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoplasia of nasal cartilages
Number of subjects: 38
Study 7525240 — intervention group
Group type: EXPERIMENTAL
Intervention: SNCV of P3 (third palmar branch)
Number of subjects: 62
Study 7525240 — intervention group
Group type: COMPARATOR
Intervention: SNCV of P2 (second palmar branch)
Number of subjects: 62
Study 7525240 — intervention group
Group type: COMPARATOR
Intervention: SNCV of M4 (ring finger)
Number of subjects: 62
Study 3298136 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b (Intron A; Schering-Plough)
Number of subjects: 14
Study 3298136 — intervention group
Group type: COMPARATOR
Intervention: Busulfan (induction therapy)
Number of subjects: 14
Study 29688834 — intervention group
Group type: EXPERIMENTAL
Intervention: My Changed Body (MyCB) intervention
Number of subjects: 304
Study 29688834 — intervention group
Group type: COMPARATOR
Intervention: Expressive writing control arm
Number of subjects: 304
Study 29688834 — intervention group
Group type: EXPERIMENTAL
Intervention: MyCB intervention
Number of subjects: 304
Study 27859619 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE‐A)
Number of subjects: 61
Study 27859619 — intervention group
Group type: COMPARATOR
Intervention: Client-Centered Therapy (CCT)
Number of subjects: 61
Study 24692613 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrocautery of the patellar rim
Number of subjects: 300
Study 24692613 — intervention group
Group type: COMPARATOR
Intervention: No electrocautery of the patellar rim
Number of subjects: 300
Study 23034724 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist Circumference (WC)
Number of subjects: 237
Study 23034724 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist-Hip Ratio (WHR)
Number of subjects: 237
Study 23034724 — intervention group
Group type: EXPERIMENTAL
Intervention: Sagittal Abdominal Diameter (SAD)
Number of subjects: 237
Study 23034724 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist-Height Ratio (WHtR)
Number of subjects: 237
Study 23034724 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist Circumference (WC) in males
Number of subjects: 237
Study 23034724 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist-Hip Ratio (WHR) in males
Number of subjects: 237
Study 23034724 — intervention group
Group type: EXPERIMENTAL
Intervention: Sagittal Abdominal Diameter (SAD) in males
Number of subjects: 237
Study 23034724 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist-Height Ratio (WHtR) in males
Number of subjects: 237
Study 23034724 — intervention group
Group type: EXPERIMENTAL
Intervention: Measures of abdominal obesity in females
Number of subjects: 237
Study 21111273 — intervention group
Group type: EXPERIMENTAL
Intervention: PCDV (Portable Oxygen Concentrator with Demand Valve)
Number of subjects: 19
Study 21111273 — intervention group
Group type: COMPARATOR
Intervention: O(2)Liq (Liquid Oxygen by Continuous Flow)
Number of subjects: 19
Study 18209510 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (5 mg twice a day)
Number of subjects: 12
Study 18209510 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 17016190 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-injection volar subcutaneous block
Number of subjects: 27
Study 17016190 — intervention group
Group type: COMPARATOR
Intervention: Two-injection dorsal block
Number of subjects: 27
Study 17016190 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference for volar block
Number of subjects: 27
Study 14530478 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined prone and supine acquisitions
Number of subjects: 3834
Study 14530478 — intervention group
Group type: COMPARATOR
Intervention: Supine-only imaging
Number of subjects: 3834
Study 11012470 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg or Lansoprazole 30 mg taken 15 min before breakfast
Number of subjects: 21
Study 11012470 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg or Lansoprazole 30 mg taken without a meal
Number of subjects: 21
Study 11012470 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole or Lansoprazole taken with breakfast (after removing the 1 h breakfast period)
Number of subjects: 21
Study 8975939 — intervention group
Group type: EXPERIMENTAL
Intervention: UFT (300 mg/day) from 5th postoperative week for one year
Number of subjects: 101
Study 8975939 — intervention group
Group type: COMPARATOR
Intervention: Epirubicin (40 mg/m2) bolus injection arterially on day 28, in addition to UFT administration
Number of subjects: 101
Study 1335638 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (CLF strain, 360 ELISA units, 0.5 mg aluminium hydroxide)
Number of subjects: 199
Study 1335638 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (HM175 strain, 180 ELISA units, 1 mg aluminium hydroxide)
Number of subjects: 199
Study 1335638 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (HM175 strain, 360 ELISA units, 0.5 mg aluminium hydroxide)
Number of subjects: 199
Study 1335638 — intervention group
Group type: EXPERIMENTAL
Intervention: Group D (HM175 strain, 360 ELISA units, 1 mg aluminium hydroxide)
Number of subjects: 199
Study 1335638 — intervention group
Group type: EXPERIMENTAL
Intervention: Group E (HM175 strain, 720 ELISA units, 1 mg aluminium hydroxide)
Number of subjects: 199
Study 380631 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 42
Study 380631 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 380631 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline (first treatment)
Number of subjects: 42
Study 380631 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment effect
Number of subjects: 42
Study 30791557 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 g of Polydextrose per day
Number of subjects: 192
Study 30791557 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 g of Polydextrose per day
Number of subjects: 192
Study 30791557 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 g of Polydextrose per day
Number of subjects: 192
Study 30791557 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study 27830395 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine (6 g/m2 per dose twice daily, maximum 10 g/dose)
Number of subjects: 56
Study 27830395 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 25611116 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health intervention (PROTECT)
Number of subjects: 315
Study 25611116 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health screening
Number of subjects: 315
Study 23937753 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoperative treatment
Number of subjects: 80
Study 23937753 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 80
Study 21909490 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-tray technique
Number of subjects: 7
Study 21909490 — intervention group
Group type: COMPARATOR
Intervention: Open-tray technique
Number of subjects: 7
Study 19824413 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketofol (ketamine/propofol ratio of 1:4)
Number of subjects: 152
Study 19824413 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketofol (higher mass fraction of ketamine)
Number of subjects: 152
Study 19824413 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketofol (general use)
Number of subjects: 152
Study 17109504 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Accelerated Irradiation (CAIR)
Number of subjects: 60
Study 17109504 — intervention group
Group type: COMPARATOR
Intervention: Conventional Irradiation (CR)
Number of subjects: 60
Study 17109504 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (CAIR and CR)
Number of subjects: 60
Study 15924620 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise program (twice weekly, one hour sessions for six weeks, performed at >= 60% of maximum heart rate)
Number of subjects: 61
Study 15924620 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-intervention)
Number of subjects: 61
Study 12511367 — intervention group
Group type: EXPERIMENTAL
Intervention: IOP reduction achieved by medical, laser, or surgical therapy in OAG patients
Number of subjects: 40
Study 12511367 — intervention group
Group type: EXPERIMENTAL
Intervention: IOP reduction achieved by medical, laser, or surgical therapy in OHT patients
Number of subjects: 40
Study 10543286 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol (12 microg) + Beclomethasone (500 microg x day(‐1))
Number of subjects: 132
Study 10543286 — intervention group
Group type: COMPARATOR
Intervention: Beclomethasone (1000 microg x day(‐1))
Number of subjects: 132
Study 7542972 — intervention group
Group type: EXPERIMENTAL
Intervention: TULIP (transurethral ultrasound-guided laser-induced prostatectomy)
Number of subjects: 0
Study 7542972 — intervention group
Group type: COMPARATOR
Intervention: TURP (transurethral resection of the prostate)
Number of subjects: 0
Study 1708961 — intervention group
Group type: EXPERIMENTAL
Intervention: Early suckling (treatment group)
Number of subjects: 160
Study 1708961 — intervention group
Group type: COMPARATOR
Intervention: Control group (delayed contact)
Number of subjects: 160
Study 1708961 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (breastfeeding prior to temperature recording)
Number of subjects: 160
Study 373903 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine (1.5 g)
Number of subjects: 75
Study 373903 — intervention group
Group type: COMPARATOR
Intervention: Pyrimethamine (75 mg) plus sulfadoxine (1.5 g)
Number of subjects: 75
Study 31991214 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin
Number of subjects: 54
Study 31991214 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampicin
Number of subjects: 54
Study 31991214 — intervention group
Group type: COMPARATOR
Intervention: Sterile saline
Number of subjects: 54
Study 29566128 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab (420 mg every 2 weeks)
Number of subjects: 63
Study 29566128 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab (monotherapy)
Number of subjects: 63
Study 29566128 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab (in combination with atorvastatin)
Number of subjects: 63
Study 29566128 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab and atorvastatin (substudy of 16 subjects)
Number of subjects: 63
Study 28303624 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 2587
Study 28303624 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2587
Study 25754148 — intervention group
Group type: EXPERIMENTAL
Intervention: Potato soup with MSG (5% w/w)
Number of subjects: 40
Study 25754148 — intervention group
Group type: COMPARATOR
Intervention: Potato soup without MSG
Number of subjects: 40
Study 24035299 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled temporary phrenic nerve palsy induced by local administration of lidocaine 1% at a rate of 3 mL/h (30 mg/h) via catheter.
Number of subjects: 10
Study 24035299 — intervention group
Group type: COMPARATOR
Intervention: No induced phrenic nerve palsy (normal function).
Number of subjects: 10
Study 21406489 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes Intensive Education Program (DIEP)
Number of subjects: 50
Study 21406489 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 50
Study 18230022 — intervention group
Group type: EXPERIMENTAL
Intervention: Social-evaluative threat (SET) condition
Number of subjects: 89
Study 18230022 — intervention group
Group type: COMPARATOR
Intervention: Presence of inattentive confederate (PRES) condition
Number of subjects: 89
Study 18230022 — intervention group
Group type: COMPARATOR
Intervention: Alone in a room (non-SET) condition
Number of subjects: 89
Study 16174016 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoablation at -70 degrees C
Number of subjects: 32
Study 16174016 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryomapping at -30 degrees C
Number of subjects: 32
Study 16174016 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency (RF) current application
Number of subjects: 32
Study 16174016 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoablation
Number of subjects: 32
Study 12768300 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (850 mg, two times per day)
Number of subjects: 50
Study 12768300 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH analogue (goserelin 3.6 mg, every 28 days)
Number of subjects: 50
Study 10376918 — intervention group
Group type: EXPERIMENTAL
Intervention: edrophonium HCl (12 to 18 mg)
Number of subjects: 28
Study 10376918 — intervention group
Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 28
Study 9091852 — intervention group
Group type: EXPERIMENTAL
Intervention: Water immersion (WI) for 2 hours
Number of subjects: 18
Study 2066823 — intervention group
Group type: EXPERIMENTAL
Intervention: Poster intervention group (weekly tracking with poster)
Number of subjects: 4772
Study 2066823 — intervention group
Group type: EXPERIMENTAL
Intervention: Poster/postcard intervention group (weekly tracking with poster and postcard reminders)
Number of subjects: 4772
Study 2066823 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 4772
Study 6799196 — intervention group
Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN) during ProMACE-MOPP treatment
Number of subjects: 74
Study 6799196 — intervention group
Group type: COMPARATOR
Intervention: Standard diet during ProMACE-MOPP treatment
Number of subjects: 74
Study 6799196 — intervention group
Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN) as an adjunct to chemotherapy or chemotherapy plus total body irradiation
Number of subjects: 74
Study 6799196 — intervention group
Group type: COMPARATOR
Intervention: Standard diet as an adjunct to chemotherapy or chemotherapy plus total body irradiation
Number of subjects: 74
Study 31941354 — intervention group
Group type: COMPARATOR
Intervention: Intravenous Amiodarone
Number of subjects: 3019
Study 31941354 — intervention group
Group type: COMPARATOR
Intervention: Intravenous Lidocaine
Number of subjects: 3019
Study 31941354 — intervention group
Group type: COMPARATOR
Intervention: Intraosseous Amiodarone
Number of subjects: 3019
Study 31941354 — intervention group
Group type: COMPARATOR
Intervention: Intraosseous Lidocaine
Number of subjects: 3019
Study 31941354 — intervention group
Group type: COMPARATOR
Intervention: Intravenous Drugs (Amiodarone or Lidocaine)
Number of subjects: 3019
Study 31941354 — intervention group
Group type: COMPARATOR
Intervention: Intraosseous Drugs (Amiodarone or Lidocaine)
Number of subjects: 3019
Study 31941354 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Intravenous and Intraosseous)
Number of subjects: 3019
Study 30883877 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% adapalene gel
Number of subjects: 0
Study 30883877 — intervention group
Group type: COMPARATOR
Intervention: 0.025% tretinoin cream
Number of subjects: 0
Study 29223956 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin treatment
Number of subjects: 9423
Study 29223956 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9423
Study 26226999 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranolazine 750 mg BID and Dronedarone 225 mg BID
Number of subjects: 134
Study 26226999 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranolazine 750 mg BID and Dronedarone 150 mg BID
Number of subjects: 134
Study 26226999 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study 26226999 — intervention group
Group type: COMPARATOR
Intervention: Ranolazine alone (750 mg BID)
Number of subjects: 134
Study 26226999 — intervention group
Group type: COMPARATOR
Intervention: Dronedarone alone (225 mg BID)
Number of subjects: 134
Study 24512944 — intervention group
Group type: EXPERIMENTAL
Intervention: brief motivational phone intervention (pBMI)
Number of subjects: 57
Study 24512944 — intervention group
Group type: COMPARATOR
Intervention: assessment only
Number of subjects: 57
Study 22113931 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitored anaesthesia care (MAC) with paracervical local anaesthesia and remifentanil
Number of subjects: 91
Study 22113931 — intervention group
Group type: COMPARATOR
Intervention: Total intravenous anaesthesia (TIVA) with propofol and remifentanil
Number of subjects: 91
Study 19208440 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate and GTN spray (group A)
Number of subjects: 83
Study 19208440 — intervention group
Group type: COMPARATOR
Intervention: Placebo drug and GTN spray (group B)
Number of subjects: 83
Study 19208440 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate and placebo spray (group C)
Number of subjects: 83
Study 19208440 — intervention group
Group type: COMPARATOR
Intervention: Placebo drug and placebo spray (group D)
Number of subjects: 83
Study 17890876 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous EPO
Number of subjects: 158
Study 17163894 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV prevention interventions targeting adolescent girls
Number of subjects: 6
Study 17163894 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of providing information and behavioral skills training
Number of subjects: 6
Study 17163894 — intervention group
Group type: EXPERIMENTAL
Intervention: Ongoing studies
Number of subjects: 6
Study 17163894 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-scale longitudinal interventions
Number of subjects: 6
Study 10958127 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 40
Study 10958127 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 40
Study 10958127 — intervention group
Group type: EXPERIMENTAL
Intervention: Both (diazepam and nitroglycerin)
Number of subjects: 40
Study 10958127 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 40
Study 9278201 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (10 mg)
Number of subjects: 28
Study 9278201 — intervention group
Group type: COMPARATOR
Intervention: Promethazine (25 mg)
Number of subjects: 28
Study 9278201 — intervention group
Group type: EXPERIMENTAL
Intervention: Niacin
Number of subjects: 28
Study 9278201 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone and Niacin combination
Number of subjects: 28
Study 9278201 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine (2.1 g base total dose) with Prednisolone
Number of subjects: 28
Study 9278201 — intervention group
Group type: EXPERIMENTAL
Intervention: No treatment with Prednisolone
Number of subjects: 28
Study 8316971 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcervical CVS
Number of subjects: 3079
Study 8316971 — intervention group
Group type: EXPERIMENTAL
Intervention: Transabdominal CVS
Number of subjects: 3079
Study 8316971 — intervention group
Group type: COMPARATOR
Intervention: Amniocentesis
Number of subjects: 3079
Study 3105310 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 g of carbohydrate in an isocaloric diet
Number of subjects: 8
Study 3105310 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g of carbohydrate in an isocaloric diet
Number of subjects: 8
Study 3105310 — intervention group
Group type: COMPARATOR
Intervention: Control dietary period
Number of subjects: 8
Study 29607766 — intervention group
Group type: EXPERIMENTAL
Intervention: FAIS-specific physical therapy group received personalized progressive strengthening and functional retraining.
Number of subjects: 24
Study 29607766 — intervention group
Group type: COMPARATOR
Intervention: Control group received standardized stretching exercises.
Number of subjects: 24
Study 27052652 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed plus carboplatin
Number of subjects: 0
Study 27052652 — intervention group
Group type: COMPARATOR
Intervention: Single-agent pemetrexed
Number of subjects: 0
Study 24486883 — intervention group
Group type: EXPERIMENTAL
Intervention: LY545694 (25mg twice daily)
Number of subjects: 27
Study 24486883 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (600mg 8 hours apart; 6 doses over 3 days)
Number of subjects: 27
Study 24486883 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 22221173 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose ursodeoxycholic acid (UDCA) at 17-23 mg/kg/day
Number of subjects: 98
Study 22221173 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 22221173 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose ursodeoxycholic acid (UDCA)
Number of subjects: 98
Study 20556559 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavocoxid (569 mg HED)
Number of subjects: 0
Study 20556559 — intervention group
Group type: COMPARATOR
Intervention: Flavocoxid combined with aspirin (370 mg HED)
Number of subjects: 0
Study 20556559 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavocoxid in healthy volunteers
Number of subjects: 0
Study 20556559 — intervention group
Group type: COMPARATOR
Intervention: Flavocoxid in previously warfarinized patients
Number of subjects: 0
Study 18338138 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal tube suction (LTS-D)
Number of subjects: 50
Study 18338138 — intervention group
Group type: COMPARATOR
Intervention: Bag-mask ventilation (BMV)
Number of subjects: 50
Study 16001913 — intervention group
Group type: EXPERIMENTAL
Intervention: Autogenous bone plus resorbable membrane (ABM)
Number of subjects: 15
Study 16001913 — intervention group
Group type: COMPARATOR
Intervention: Autogenous iliac bone graft (ABG)
Number of subjects: 15
Study 16001913 — intervention group
Group type: COMPARATOR
Intervention: Nonresorbable expanded polytetrafluoroethylene Gore‐Tex TR membrane (GTM)
Number of subjects: 15